Advertisement

Parexel International Corp., the Waltham-based contract research organization, said it was selected as one of two strategic partners by Pfizer Inc. to provide clinical development services.

No amount was disclosed for the deal, but Parexel said in a press release that it plans to provide financial guidance, including the effect of this agreement, on June 1 in conjunction with its annual Investor Day. The other partner is Icon Plc of Dublin, Ireland.

SOURCE

Advertisement
Advertisement